PDS Biotechnology
PDSB
₹106.36
Share price
-4.62%
Change (1 day)
-68.86%
Change (1 year)
Categories
PDS Biotechnology (PDSB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : ₹2.11 Billion
According to PDS Biotechnology 's latest financial reports the company's total liabilities are ₹2.11 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
PDS Biotechnology - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | ₹2.76 B | 1.37% |
| 2022-12-31 | ₹2.73 B | 820.26% |
| 2021-12-31 | ₹0.29 B | 7.91% |
| 2020-12-31 | ₹0.27 B | 38.07% |
| 2019-12-31 | ₹0.19 B | -55.36% |
| 2018-12-31 | ₹0.44 B | -76.9% |
| 2017-12-31 | ₹1.93 B | 31.36% |
| 2016-12-31 | ₹1.47 B | 90.49% |
| 2015-12-31 | ₹0.77 B | -72.74% |
| 2014-12-31 | ₹2.83 B | 90.32% |
| 2013-12-31 | ₹1.48 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | ₹1.98 B | -6.27% | 🇺🇸 USA |